Products
Research Areas
COVID-19
Resources
Contact Us
Distributors
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us
LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121
Phone:
206-374-1102
Fax:
206-577-4565
How To Buy - Details about how to buy our products.
Orders@LSBio.com - To submit a new order.
Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, Proforma invoice requests, or other billing issues.
Technical.Support@LSBio.com - To request technical information about an LSBio product or its applications
Sales@LSBio.com - To request information about distribution agreements, or general business development.
Worldwide Distributors List - To find your local distributor if you're not within the United States.
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C18995-100 100 µl (85 mg/ml) $498 
FBXO4 / FBX4 Antibody - Whole cell extracts prepared from U2OS cells, or insect Sf9 cells expressing Flag-FBX4, were resolved by SDS-PAGE and transferred to nitrocellulose. FBX4 antibody was used at a 1:500 dilution, in TBS buffer containing 0.1% Tween-20, followed by peroxidase conjugated anti-rabbit IgG.

Polyclonal Rabbit anti‑Human FBXO4 / FBX4 Antibody (N‑Terminus, WB) LS‑C18995

Polyclonal Rabbit anti‑Human FBXO4 / FBX4 Antibody (N‑Terminus, WB) LS‑C18995

Antibody:
FBXO4 / FBX4 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
WB, ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified
Price
Catalog Number
$498
LS-C18995-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
FBXO4 / FBX4 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
WB, ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified

Specifications

Description
FBX4 antibody LS-C18995 is an unconjugated rabbit polyclonal antibody to FBX4 (FBXO4) (N-Terminus) from human. It is reactive with human and mouse. Validated for ELISA and WB.
Target
Human FBXO4 / FBX4
Synonyms
FBXO4 | F-box protein 4 | F-box protein Fbx4 | FBX4 | F-box only protein 4
Host
Rabbit
Reactivity
Human, Mouse (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Antiserum
Modifications
Unmodified
Immunogen
This whole rabbit serum was prepared by repeated immunizations with a synthetic peptide derived from sequences unique to the N-terminus of FBX4 and conserved between the human and murine proteins.
Epitope
N-Terminus
Specificity
This antiserum is directed against human and mouse FBX4. Reactivity against homologues from other sources is not known.
Applications
  • Western blot (1:500 - 1:3000)
  • ELISA (1:5000 - 1:25000)
Usage
This antiserum has been tested for use in western blotting. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 44 kD in size by western blotting in the appropriate cell lysate or extract. Western Blot 1:500 - 1:3000;
Presentation
0.02 M Potassium Phosphate, pH 7.2, 0.15 M NaCl, 0.01% Sodium Azide
Storage
Store vial at -20°C or below prior to opening. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About FBXO4 / FBX4
Q9UKT5 NM_012176 Q9UKT5

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 8/10/2022